Excluding JAK2 V617F mutation analysis from the primary immune thrombocytopenia 'diagnosis of exclusion'
- PMID: 36409925
- DOI: 10.1097/MBC.0000000000001173
Excluding JAK2 V617F mutation analysis from the primary immune thrombocytopenia 'diagnosis of exclusion'
Comment on
-
Primary immune thrombocytopenia: a 'diagnosis of exclusion'?Blood Coagul Fibrinolysis. 2022 Sep 1;33(6):289-294. doi: 10.1097/MBC.0000000000001144. Epub 2022 Jul 29. Blood Coagul Fibrinolysis. 2022. PMID: 35867940 Free PMC article.
References
-
- Visweshwar N, Ayala I, Jaglal M, Killeen R, Sokol L, Laber DA, et al. Primary immune thrombocytopenia: a ‘diagnosis of exclusion’? Blood Coagul Fibrinolysis 2022; 33:289–294.
-
- Yilmaz M, Verstovsek S. Managing patients with myelofibrosis and thrombocytopenia. Expert Rev Hematol 2022; 15:233–241.
-
- Pastor-Galán I, Martín I, Ferrer B, Hernández-Boluda JC. Impact of molecular profiling on the management of patients with myelofibrosis. Cancer Treat Rev 2022; 109:102435.
-
- Sobas M, Podolak-Dawidziak M, Lewandowski K, Bator M, Wróbel T. Primary immune thrombocytopenia and essential thrombocythemia: so different and yet somehow similar – case series and review of the literature. Int J Mol Sci 2021; 22:10918.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
